MedPath

WAKEMED HEALTH AND HOSPITALS

WAKEMED HEALTH AND HOSPITALS logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

sTErnAl heMostasiS Trial

Phase 4
Not yet recruiting
Conditions
Excessive Bleeding During Surgery
Interventions
Drug: Hemoblast Bellows application
First Posted Date
2024-07-22
Last Posted Date
2024-07-24
Lead Sponsor
WakeMed Health and Hospitals
Target Recruit Count
60
Registration Number
NCT06511778
Locations
🇺🇸

WakeMed Health and Hospitals, Raleigh, North Carolina, United States

Prevention of Post-OP AFib Using Combination of CardiaMend and Amiodarone

Phase 4
Completed
Conditions
Post Operative Atrial Fibrillation
Interventions
Combination Product: CardiaMend with the Addition of Amiodarone
First Posted Date
2023-01-12
Last Posted Date
2024-02-22
Lead Sponsor
WakeMed Health and Hospitals
Target Recruit Count
30
Registration Number
NCT05681182
Locations
🇺🇸

WakeMed Health and Hospitals, Raleigh, North Carolina, United States

RESPECT Heart Failure- RESpiratory Pattern Evaluation in Clinical Trials for HF

Not Applicable
Withdrawn
Conditions
Heart Failure
Interventions
Other: MouthLab Device
First Posted Date
2021-02-17
Last Posted Date
2022-10-24
Lead Sponsor
WakeMed Health and Hospitals
Registration Number
NCT04757246
Locations
🇺🇸

WakeMed Health and Hospitals, Raleigh, North Carolina, United States

Study of Birth Control Use After Childbirth

Not Applicable
Completed
Conditions
Contraception
Interventions
Behavioral: LARC Script
First Posted Date
2011-09-29
Last Posted Date
2012-06-28
Lead Sponsor
WakeMed Health and Hospitals
Target Recruit Count
800
Registration Number
NCT01443533
Locations
🇺🇸

WakeMed Hospital, Raleigh, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath